•
Sep 30, 2021

PROCEPT BioRobotics Q3 2021 Earnings Report

Reported third quarter results with revenue increase driven by system sales to new and existing hospital customers.

Key Takeaways

PROCEPT BioRobotics reported strong third-quarter results, with total revenue reaching $8.7 million, a significant increase from $2.1 million in the prior year period. The company's U.S. system revenue was $5.0 million, compared to $0.6 million in the prior year period. The company issued 2021 total revenue guidance range of $33.0 to $33.3 million.

Total revenue for Q3 2021 was $8.7 million, compared to $2.1 million in the prior year period.

U.S. system revenue for Q3 2021 was $5.0 million, compared to $0.6 million in the prior year period.

U.S. handpiece revenue for Q3 2021 was $2.2 million, compared to $0.5 million in the prior year period.

International revenue for Q3 2021 was $1.3 million, compared to $1.0 million in the prior year period.

Total Revenue
$8.67M
Previous year: $4.5M
+92.8%
EPS
-$1.22
Previous year: -$53.9
-97.7%
Gross Margin
48.9%
Previous year: -1%
-4990.0%
Installed Base (US)
75
Gross Profit
$4.24M
Previous year: -$31K
-13777.4%
Cash and Equivalents
$320M
Previous year: $113M
+182.7%
Free Cash Flow
-$12.9M
Previous year: -$35.1M
-63.4%
Total Assets
$351M

PROCEPT BioRobotics

PROCEPT BioRobotics

PROCEPT BioRobotics Revenue by Segment

PROCEPT BioRobotics Revenue by Geographic Location

Forward Guidance

The Company expects full year 2021 revenue to be in the range of $33.0 to $33.3 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income